1014
A 58-yr-old male patient with essential thrombocythaemia (ET) developed chronic myeloid leukaemia (CML) after continuous uneventful treatment with hydroxyurea for 18 yr.
 A 58-yr-old male patient with essential thrombocythaemia (ET): Subject; 58-yr-old: Subject.Age; male: Subject.Gender; chronic myeloid leukaemia (CML): Effect; continuous uneventful treatment with hydroxyurea for 18 yr: Treatment; essential thrombocythaemia (ET): Treatment.Disorder; hydroxyurea: Treatment.Drug; 18 yr: Treatment.Duration
Given event type and trigger, please tell me the arguments of all the listed option. Output format is "name1: role1; name2: role2". 
Event type: adverse event 
  Option: Treatment.Freq, Subject.Population, Combination.Drug, Subject.Gender, Treatment.Duration, Subject, Effect, Treatment, Treatment.Disorder, Subject.Disorder, Treatment.Route, Subject.Race, Treatment.Time_elapsed, Treatment.Dosage, Subject.Age, Treatment.Drug 
Text: {0} 
Answer:
 A 58-yr-old male patient with essential thrombocythaemia (ET): Subject; 58-yr-old: Subject.Age; male: Subject.Gender; chronic myeloid leukaemia (CML): Effect; continuous uneventful treatment with hydroxyurea for 18 yr: Treatment; essential thrombocythaemia (ET): Treatment.Disorder; hydroxyurea: Treatment.Drug; 18 yr: Treatment.Duration